The genetics of Alzheimer's disease

Handbook of Clinical Neurology - Tập 89 - Trang 223-232 - 2008
Lars Bertram1
1MassGeneral Institute for Neurodegenerative Diseases (MIND), Massachusetts General Hospital, Charlestown, MA, USA

Tài liệu tham khảo

Adighibe, 2005, Genetic variability at the LXR gene (NR1H2) may contribute to the risk of Alzheimer's disease, Neurobiol Aging, 27, 1431, 10.1016/j.neurobiolaging.2005.08.010 Arango, 2001, Systematic genetic study of Alzheimer disease in Latin America: mutation frequencies of the amyloid beta precursor protein and presenilin genes in Colombia, Am J Med Genet, 103, 138, 10.1002/1096-8628(20011001)103:2<138::AID-AJMG1529>3.0.CO;2-8 Bales, 1999, Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease, Proc Natl Acad Sci USA, 96, 15233, 10.1073/pnas.96.26.15233 Beffert, 1999, Apolipoprotein E and beta‐amyloid levels in the hippocampus and frontal cortex of Alzheimer's disease subjects are disease‐related and apolipoprotein E genotype dependent, Brain Res, 843, 87, 10.1016/S0006-8993(99)01894-6 Bertram, 2003, 40 Bertram, 2004, Alzheimer's disease: One disorder, too many genes?, Hum Mol Genet, 13, R135, 10.1093/hmg/ddh077 Bertram, 2004, PEN2 is not a genetic risk factor for Alzheimer's disease in a large family sample, Neurology, 62, 304, 10.1212/01.WNL.0000103283.65914.0B Bertram, 2007, Systematic Meta‐Analyses of Alzheimer Disease Genetic Association Studies: The AlzGene Database, Nat Genet, 39, 17, 10.1038/ng1934 Blacker, 1997, Apoe‐4 and age at onset of Alzheimer's disease: the NIMH genetics initiative, Neurology, 48, 139, 10.1212/WNL.48.1.139 Blacker, 2003, Results of a high‐resolution genome screen of 437 Alzheimer's Disease families, Hum Mol Genet, 12, 23, 10.1093/hmg/ddg007 Brouwers, 2006, Genetic risk and transcriptional variability of amyloid precursor protein in Alzheimer's disease, Brain, 129, 2984, 10.1093/brain/awl212 Burke, 2001, Categorizing genetic tests to identify their ethical, legal, and social implications, Am J Med Genet, 106, 233, 10.1002/ajmg.10011 Corder, 1994, Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease, Nat Genet, 7, 180, 10.1038/ng0694-180 Daw, 2000, The number of trait loci in late‐onset Alzheimer disease, Am J Hum Genet, 66, 196, 10.1086/302710 Farrer, 1997, Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta‐analysis. APOE and Alzheimer Disease Meta Analysis Consortium, JAMA, 278, 1349, 10.1001/jama.1997.03550160069041 Finckh, 2003, The future of genetic association studies in Alzheimer disease, J Neural Transm, 110, 253, 10.1007/s00702-002-0775-7 Gatz, 2006, Role of genes and environments for explaining Alzheimer disease, Arch Gen Psychiatry, 63, 168, 10.1001/archpsyc.63.2.168 Goate, 1991, Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease, Nature, 349, 704, 10.1038/349704a0 Hardy, 2002, The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics, Science, 297, 353, 10.1126/science.1072994 Ioannidis, 2003, Genetic associations in large versus small studies: an empirical assessment, Lancet, 361, 567, 10.1016/S0140-6736(03)12516-0 Irizarry, 2004, Apolipoprotein E modulates gamma‐secretase cleavage of the amyloid precursor protein, J Neurochem, 90, 1132, 10.1111/j.1471-4159.2004.02581.x Keavney, 2000, Large‐scale test of hypothesised associations between the angiotensin‐converting‐enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls. International Studies of Infarct Survival (ISIS) Collaborators, Lancet, 355, 434, 10.1016/S0140-6736(00)82009-7 Levy‐Lahad, 1995, Candidate gene for the chromosome 1 familial Alzheimer's disease locus, Science, 269, 973, 10.1126/science.7638622 Li, 2005, Serum cholesterol and risk of Alzheimer disease: A community‐based cohort study, Neurology, 65, 1045, 10.1212/01.wnl.0000178989.87072.11 Lleo, 2002, Frequency of mutations in the presenilin and amyloid precursor protein genes in early‐onset Alzheimer disease in Spain, Arch Neurol, 59, 1759, 10.1001/archneur.59.11.1759 Lohmueller, 2003, Meta‐analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease, Nat Genet, 33, 177, 10.1038/ng1071 Mahley, 2006, Apolipoprotein E4: A causative factor and therapeutic target in neuropathology, including Alzheimer's disease, Proc Natl Acad Sci USA, 103, 5644, 10.1073/pnas.0600549103 Meyer, 1998, APOE genotype predicts when–not whether–one is predisposed to develop Alzheimer disease, Nat Genet, 19, 321, 10.1038/1206 Mullan, 1992, A locus for familial early‐onset Alzheimer's disease on the long arm of chromosome 14, proximal to the alpha 1‐antichymotrypsin gene, Nat Genet, 2, 340, 10.1038/ng1292-340 Nacmias, 1995, Apoe genotype and familial Alzheimer's disease: a possible influence on age of onset in APP717 Val‐‐>Ile mutated families, Neurosci Lett, 183, 1, 10.1016/0304-3940(94)11100-W Ostojic, 2004, The tau R406W mutation causes progressive presenile dementia with bitemporal atrophy, Dement Geriatr Cogn Disord, 17, 298, 10.1159/000077158 Ott, 1998, Incidence and risk of dementia. The Rotterdam Study, Am J Epidemiol, 147, 574, 10.1093/oxfordjournals.aje.a009489 Pericak‐Vance, 1991, Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage, Am J Hum Genet, 48, 1034 Poduslo, 2001, A new locus on chromosome 19 linked with late‐onset Alzheimer's disease, Neuroreport, 12, 3759, 10.1097/00001756-200112040-00031 Poirier, 2000, Apolipoprotein E and Alzheimer's disease. A role in amyloid catabolism, Ann N Y Acad Sci, 924, 81, 10.1111/j.1749-6632.2000.tb05564.x Rademakers, 2003, Tau (MAPT) mutation Arg406Trp presenting clinically with Alzheimer disease does not share a common founder in Western Europe, Hum Mutat, 22, 409, 10.1002/humu.10269 Rademakers, 2005, Linkage and association studies identify a novel locus for Alzheimer disease at 7q36 in a dutch population‐based sample, Am J Hum Genet, 77, 643, 10.1086/491749 Raux, 2005, Molecular diagnosis of autosomal dominant early onset Alzheimer's disease: an update, J Med Genet, 42, 793, 10.1136/jmg.2005.033456 Reitz, 2004, Relation of plasma lipids to Alzheimer disease and vascular dementia, Arch Neurol, 61, 705, 10.1001/archneur.61.5.705 Risch, 1996, The future of genetic studies of complex human diseases, Science, 273, 1516, 10.1126/science.273.5281.1516 Rocchi, 2003, Causative and susceptibility genes for Alzheimer's disease: a review, Brain Res Bull, 61, 1, 10.1016/S0361-9230(03)00067-4 Rogaev, 1995, Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene, Nature, 376, 775, 10.1038/376775a0 Rosso, 2003, Frontotemporal dementia in The Netherlands: patient characteristics and prevalence estimates from a population‐based study, Brain, 126, 2016, 10.1093/brain/awg204 Rovelet‐Lecrux, 2006, APP locus duplication causes autosomal dominant early‐onset Alzheimer disease with cerebral amyloid angiopathy, Nat Genet, 38, 24, 10.1038/ng1718 Rumble, 1989, Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease, N Engl J Med, 320, 1446, 10.1056/NEJM198906013202203 Sala Frigerio, 2005, PEN‐2 gene mutation in a familial Alzheimer's disease case, J Neurol, 252, 1033, 10.1007/s00415-005-0799-7 Saunders, 1993, Association of apolipoprotein E allele epsilon 4 with late‐onset familial and sporadic Alzheimer's disease, Neurology, 43, 1467, 10.1212/WNL.43.8.1467 Schellenberg, 1992, Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14, Science, 258, 668, 10.1126/science.1411576 Sherrington, 1995, Cloning of a gene bearing missense mutations in early‐onset familial Alzheimer's disease, Nature, 375, 754, 10.1038/375754a0 Sisodia, 2002, γ‐Secretase, notch, Aβ and Alzheimer's disease: where do the presenilins fit in?, Nat Rev Neurosci, 3, 281, 10.1038/nrn785 Sleegers, 2006, APP duplication is sufficient to cause early onset Alzheimer's dementia with cerebral amyloid angiopathy, Brain, 129, 2977, 10.1093/brain/awl203 St George‐Hyslop, 1992, Genetic evidence for a novel familial Alzheimer's disease locus on chromosome 14, Nat Genet, 2, 330, 10.1038/ng1292-330 Strittmatter, 1993, Apolipoprotein E: high‐avidity binding to beta‐amyloid and increased frequency of type 4 allele in late‐onset familial Alzheimer disease, Proc Natl Acad Sci USA, 90, 1977, 10.1073/pnas.90.5.1977 Tanzi, 1999, A genetic dichotomy model for the inheritance of Alzheimer's disease and common age‐related disorders, J Clin Invest, 104, 1175, 10.1172/JCI8593 Tanzi, 2005, Twenty years of the Alzheimer's disease amyloid hypothesis: A genetic perspective, Cell, 120, 545, 10.1016/j.cell.2005.02.008 Tanzi, 1987, Amyloid beta protein gene: cdna, mrna distribution, and genetic linkage near the Alzheimer locus, Science, 235, 880, 10.1126/science.2949367 Theuns, 2006, Promoter mutations that increase amyloid precursor‐protein expression are associated with Alzheimer disease, Am J Hum Genet, 78, 936, 10.1086/504044 Van Broeckhoven, 1992, Mapping of a gene predisposing to early‐onset Alzheimer's disease to chromosome 14q24.3, Nat Genet, 2, 335, 10.1038/ng1292-335 Wijsman, 2004, Evidence for a novel late‐onset Alzheimer disease locus on chromosome 19p13.2, Am J Hum Genet, 75, 398, 10.1086/423393 Wisniewski, 1985, Alzheimer's disease in Down's syndrome: Clinicopathologic studies, Neurology, 35, 957, 10.1212/WNL.35.7.957 Wragg, 1996, Genetic association between intronic polymorphism in presenilin‐1 gene and late‐onset Alzheimer's disease. Alzheimer's Disease Collaborative Group, Lancet, 347, 509, 10.1016/S0140-6736(96)91140-X